Number of the records: 1  

IgA nephropathy enigma

  1. 1.
    SYSNO ASEP0469665
    Document TypeJ - Journal Article
    R&D Document TypeJournal Article
    Subsidiary JČlánek ve WOS
    TitleIgA nephropathy enigma
    Author(s) Městecký, Jiří (MBU-M) ORCID
    Novák, J. (US)
    Moldoveanu, Z. (US)
    Raška, M. (CZ)
    Source TitleClinical Immunology. - : Elsevier - ISSN 1521-6616
    Roč. 172, NOV 2016 SI (2016), s. 72-77
    Number of pages6 s.
    Languageeng - English
    CountryUS - United States
    KeywordsIgA nephropathy ; IgA subclasses ; Autoimmunity
    Subject RIVEE - Microbiology, Virology
    R&D ProjectsNV15-33686A GA MZd - Ministry of Health (MZ)
    Institutional supportMBU-M - RVO:61388971
    UT WOS000388056200012
    EID SCOPUS84993999910
    DOI10.1016/j.clim.2016.07.011
    AnnotationIgA nephropathy (IgAN) is the leading cause of primary glomerulonephritis in the world. The disease is characterized by the presence of IgA-containing immune complexes in the circulation and in mesangial deposits with ensuing glomerular injury. Although in humans there are two IgA subclasses, only IgA1 molecules are involved. The exclusivity of participation of IgA1 in IgAN prompted extensive structural and immunological studies of the unique hinge region (HR) of IgA1, which is absent in otherwise highly homologous IgA2. HR of IgA1 with altered O-glycans serves as an antigen recognized by autoantibodies specific for aberrant HR glycans leading to the generation of nephritogenic immune complexes. However, there are several unresolved questions concerning the phylogenetic origin of human IgA1 HR, the structural basis of its antigenicity, the origin of antibodies specific for HR with altered glycan moieties, the regulatory defects in IgAl glycosylation pathways, and the potential approaches applicable to the disease-specific interventions in the formation of nephritogenic immune complexes. This review focuses on the gaps in our knowledge of molecular and cellular events that are involved in the immunopathogenesis of IgAN.
    WorkplaceInstitute of Microbiology
    ContactEliška Spurná, eliska.spurna@biomed.cas.cz, Tel.: 241 062 231
    Year of Publishing2017
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.